Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Newron
ClinicalTrials.gov Identifier:
NCT01027169
First received: December 3, 2009
Last updated: March 27, 2013
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)